NYSE:SYK

Stryker (SYK) Stock Forecast, Price & News

$276.73

-1.24 (-0.45%)

(As of 06/8/2023 ET)

Compare

Today's Range: $275.75
▼
$278.69
50-Day Range: $271.49
▼
$303.54
52-Week Range: $188.84
▼
$306.56

Volume: 963,711 shs
Average Volume: 1.31 million shs
Market Capitalization: $104.83 billion

P/E Ratio: 40.28
Dividend Yield: 1.08%
Price Target: $302.00

Stryker MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 9.1% Upside
$302.00 Price Target
Short Interest: Healthy
0.88% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.95
Upright™ Environmental Score
News Sentiment: 0.56
Based on 7 Articles This Week
Insider Trading: Selling Shares
$425,250 Sold Last Quarter
Proj. Earnings Growth: 9.94%
From $10.16 to $11.17 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

22nd out of 981 stocks

Surgical & Medical Instruments Industry

2nd out of 98 stocks

2.3

Analyst's Opinion

Consensus Rating
Stryker has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 12 buy ratings, 8 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $302.00, Stryker has a forecasted upside of 9.1% from its current price of $276.73.
Amount of Analyst Coverage
Stryker has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
0.88% of the float of Stryker has been sold short.
Short Interest Ratio / Days to Cover
Stryker has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Stryker has recently decreased by 21.01%, indicating that investor sentiment is improving significantly.

4.2

Dividend Strength

Dividend Yield
Stryker pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Stryker has been increasing its dividend for 29 years.
Dividend Coverage
The dividend payout ratio of Stryker is 43.67%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Stryker will have a dividend payout ratio of 26.86% next year. This indicates that Stryker will be able to sustain or increase its dividend.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Stryker has received a 60.46% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Protective clothing", "Synthetic bone grafts", "Surgery simulation software", "Medical laboratory equipment", and "Bone cement" products. See details.
Environmental Sustainability
The Environmental Impact score for Stryker is -0.95.

1.4

News and Social Media Coverage

News Sentiment
Stryker has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Stryker this week, compared to 7 articles on an average week.
Search Interest
Only 18 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -58% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $425,250.00 in company stock.
Percentage Held by Insiders
Only 5.90% of the stock of Stryker is held by insiders.
Percentage Held by Institutions
77.10% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Stryker are expected to grow by 9.94% in the coming year, from $10.16 to $11.17 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Stryker is 40.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.96.
Price to Earnings Ratio vs. Sector
The P/E ratio of Stryker is 40.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 107.01.
Price to Earnings Growth Ratio
Stryker has a PEG Ratio of 2.89. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Stryker has a P/B Ratio of 6.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Stryker (NYSE:SYK) Stock

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

June 1, 2023 | marketbeat.com

20 Best Healthcare Dividend Stocks to Invest in (SYK)

Healthcare, like many other sectors, produces dividends. Learn more about how to invest in healthcare trends and earn dividends along the way with MarketBeat.

May 30, 2023 | marketbeat.com

Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs (SYK)

Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning

June 8, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

May 23, 2023 | marketbeat.com

Microbot Medical spikes 150% on its Endovascular Surgical Robot (SYK)

Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERT

June 8, 2023 | americanbankingnews.com

Stryker Co. (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts

June 7, 2023 | americanbankingnews.com

Srikant M. Datar Sells 500 Shares of Stryker Co. (NYSE:SYK) Stock

June 5, 2023 | msn.com

RBC Capital Reiterates Stryker (SYK) Outperform Recommendation

June 2, 2023 | forbes.com

Should You Pick Stryker Stock Over BAX For Better Returns?

June 8, 2023 | Behind the Markets (Ad)

Here's something only a handful of people know

On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...

May 31, 2023 | finance.yahoo.com

Stryker's (SYK) Q Guidance Successful in First Surgery

May 31, 2023 | finance.yahoo.com

Why Is Stryker (SYK) Down 7.6% Since Last Earnings Report?

May 30, 2023 | msn.com

The Argument for and Against Stryker Returning in Mortal Kombat 1

May 30, 2023 | finance.yahoo.com

The Zacks Analyst Blog Highlights Apple, Chevron, Accenture, Broadcom and Stryker

May 29, 2023 | msn.com

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,900 Today

May 28, 2023 | americanbankingnews.com

Stryker (NYSE:SYK) PT Raised to $310.00

May 28, 2023 | americanbankingnews.com

Stryker (NYSE:SYK) Price Target Raised to $310.00 at Argus

May 24, 2023 | finance.yahoo.com

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

May 22, 2023 | finance.yahoo.com

3 Healthcare Trends to Ride for Longevity

May 17, 2023 | americanbankingnews.com

Zacks Research Brokers Raise Earnings Estimates for Stryker Co. (NYSE:SYK)

May 12, 2023 | msn.com

Stryker (SYK) Declares $0.75 Dividend

May 12, 2023 | americanbankingnews.com

Stryker Co. (NYSE:SYK) Receives $300.86 Average PT from Analysts

May 11, 2023 | msn.com

$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today

May 11, 2023 | finance.yahoo.com

Healthcare Stocks Are on Sale. Pfizer and Stryker Have Strong Growth Prospects.

May 10, 2023 | marketwatch.com

Stryker Corp. stock outperforms competitors on strong trading day

May 10, 2023 | marketwatch.com

Stryker Corp. stock falls Tuesday, underperforms market

May 6, 2023 | americanbankingnews.com

92 Resources Reaffirms "Maintains" Rating for Stryker (NYSE:SYK)

May 5, 2023 | americanbankingnews.com

Stryker (NYSE:SYK) Price Target Raised to $345.00

See More Headlines

SYK Price History

30 days | 90 days | 365 days | Advanced Chart

SYK Company Calendar

Ex-Dividend for 4/28 Dividend: 3/30/2023
Dividend Payable: 4/28/2023
Last Earnings: 5/01/2023
Today: 6/08/2023
Ex-Dividend for 7/31 Dividend: 6/29/2023
Next Earnings (Estimated): 7/25/2023
Dividend Payable: 7/31/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:SYK
CUSIP: 86366710
CIK: 310764
Web: www.strykercorp.com
Phone: (269) 385-2600
Fax: 269-385-1062
Employees: 51,000
Year Founded: 1941

Price Target and Rating

Average Stock Price Forecast: $302.00
High Stock Price Forecast: $345.00
Low Stock Price Forecast: $220.00
Forecasted Upside/Downside: +9.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 20 Analysts

Profitability

EPS (Most Recent Fiscal Year): $6.87
Trailing P/E Ratio: 40.31
Forward P/E Ratio: 27.26
P/E Growth: 2.89
Net Income: $2.36 billion
Net Margins: 13.86%
Pretax Margin: 15.70%
Return on Equity: 22.17%
Return on Assets: 9.99%

Debt

Debt-to-Equity Ratio: 0.70
Current Ratio: 1.73
Quick Ratio: 0.99

Sales & Book Value

Annual Sales: $18.95 billion
Price / Sales: 5.54
Cash Flow: $12.09 per share
Price / Cash Flow: 22.91
Book Value: $43.91 per share
Price / Book: 6.31

Miscellaneous

Outstanding Shares: 378,831,000
Free Float: 356,480,000
Market Cap: $104.92 billion
Optionable: Optionable
Beta: 0.94

Social Links

Key Executives

Kevin A. Lobo
Chairman, President & Chief Executive Officer

Viju S. Menon
Group President-Global Quality & Operations

Glenn S. Boehnlein
Chief Financial Officer & Vice President

Alan Douville
Chief Information Officer & Vice President

Dana S. McMahon
Chief Compliance Officer & Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?: 20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 8 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.
What is Stryker's stock price forecast for 2023?: 20 brokers have issued 12-month price targets for Stryker's shares. Their SYK share price forecasts range from $220.00 to $345.00. On average, they anticipate the company's share price to reach $302.00 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.
How have SYK shares performed in 2023?: Stryker's stock was trading at $244.49 at the start of the year. Since then, SYK stock has increased by 13.3% and is now trading at $276.95.
View the best growth stocks for 2023 here.
Are investors shorting Stryker?: Stryker saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,120,000 shares, a decline of 21.0% from the April 30th total of 3,950,000 shares. Based on an average daily trading volume, of 1,250,000 shares, the short-interest ratio is currently 2.5 days. Currently, 0.9% of the shares of the company are sold short.
View Stryker's Short Interest.
When is Stryker's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our SYK earnings forecast.
How were Stryker's earnings last quarter?: Stryker Co. (NYSE:SYK) posted its earnings results on Monday, May, 1st. The medical technology company reported $2.14 earnings per share for the quarter, beating analysts' consensus estimates of $2.00 by $0.14. The medical technology company earned $4.80 billion during the quarter, compared to analyst estimates of $4.56 billion. Stryker had a trailing twelve-month return on equity of 22.17% and a net margin of 13.86%. The firm's revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.97 EPS.
Read the conference call transcript.
How often does Stryker pay dividends? What is the dividend yield for Stryker?: Stryker announced a quarterly dividend on Wednesday, May 10th. Investors of record on Friday, June 30th will be paid a dividend of $0.75 per share on Monday, July 31st. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend is Thursday, June 29th.
Read our dividend analysis for SYK.
What ETFs hold Stryker's stock?: ETFs with the largest weight of Stryker (NYSE:SYK) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), AdvisorShares Focused Equity ETF (CWS), 2ndVote Life Neutral Plus ETF (LYFE), Global X Aging Population ETF (AGNG), 2ndVote Society Defended ETF (EGIS), Democratic Large Cap Core ETF (DEMZ), Dividend Performers ETF (IPDP) and First Trust Indxx Medical Devices ETF (MDEV).
Is Stryker a good dividend stock?: Stryker (NYSE:SYK) pays an annual dividend of $3.00 per share and currently has a dividend yield of 1.08%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 43.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 26.86% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.
What guidance has Stryker issued on next quarter's earnings?: Stryker updated its FY23 earnings guidance on Monday, May, 1st. The company provided EPS guidance of $10.05-$10.25 for the period, compared to the consensus estimate of $10.00.

What is Kevin A. Lobo's approval rating as Stryker's CEO?: 1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Stryker own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).
What is Stryker's stock symbol?: Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."
Who are Stryker's major shareholders?: Stryker's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.50%), Greenleaf Trust (5.08%), Wellington Management Group LLP (4.26%), Price T Rowe Associates Inc. MD (3.77%), State Street Corp (3.70%) and Bank of New York Mellon Corp (1.76%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, James Andrew Pierce, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar, Timothy J Scannell, Viju Menon and William E Berry Jr.
View institutional ownership trends.
How do I buy shares of Stryker?: Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Stryker's stock price today?: One share of SYK stock can currently be purchased for approximately $276.95.
How much money does Stryker make?: Stryker (NYSE:SYK) has a market capitalization of $104.92 billion and generates $18.95 billion in revenue each year. The medical technology company earns $2.36 billion in net income (profit) each year or $6.87 on an earnings per share basis.
How many employees does Stryker have?: The company employs 51,000 workers across the globe.
Does Stryker have any subsidiaries?: The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
How can I contact Stryker?: Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial